Total | Negative | Positive | Sensitivity % | |
Overall | 196 | 70 | 123 | 64 |
Histology | ||||
ADK | 141 | 63 | 75 | 53 |
SCC | 24 | 2 | 22 | 92 |
Other NSCLC | 11 | 2 | 9 | 82 |
SCLC+LCNET | 13 | 1 | 12 | 92 |
Carcinoid | 5 | 1 | 4 | 80 |
Grade | ||||
G1 | 36 | 28 | 8 | 22 |
G2 | 61 | 19 | 42 | 69 |
G3 | 48 | 6 | 39 | 87 |
Unknown | 51 | 17 | 34 | 67 |
Stage | ||||
I | 127 | 78 | 47 | 38 |
II–IV | 66 | 14 | 51 | 78 |
Unknown | 3 | 2 | 1 | 33 |
Data are presented as n, unless otherwise stated. Visual examination results were unavailable for three nodules examined by PET-CT, and histological subtype was not available for all nodules. ADK: adenocarcinoma; SCC: squamous cell carcinoma; NSCLC: nonsmall cell lung cancer; SCLC: small cell lung cancer; LCNET: large cell neuroendocrine tumour.